Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 011123
Company: BRISTOL MYERS SQUIBB
Company: BRISTOL MYERS SQUIBB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
VESPRIN | TRIFLUPROMAZINE HYDROCHLORIDE | 10MG | TABLET;ORAL | Discontinued | None | No | No |
VESPRIN | TRIFLUPROMAZINE HYDROCHLORIDE | 25MG | TABLET;ORAL | Discontinued | None | No | No |
VESPRIN | TRIFLUPROMAZINE HYDROCHLORIDE | 50MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/16/1957 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Label is not available on this site. |